As of 2025-08-10, the Fair Value of Ionis Pharmaceuticals Inc (IONS) is -8.43 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 41.64 USD, the upside of Ionis Pharmaceuticals Inc is -120.24%.
With the market price of 41.64 USD and our fair value calculation, Ionis Pharmaceuticals Inc (IONS) is not a good investment. Investing in IONS stocks now will result in a potential loss of 120.24%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -444.30 | -28.60 | -269.70 | -366.29 | -453.90 | -312.56 |
| YoY growth | -259.76% | 93.56% | -843.01% | -35.81% | -23.92% | -213.79% |
| Market Cap (mil) | 6,627.42 |
| P/E | |
| Forward P/E |
| EPS | -1.69 |
| Avg earnings growth rate | -213.79% |
| TTM earnings | -268.22 |